Acquisition Insight Pal Med Inc was acquired by Solara Medical Supplies in December 2018, indicating a channel shift and potential integration into a larger diabetic supply ecosystem. Sales opportunities may exist by aligning with Solara’s distribution network or targeting post-acquisition customers.

Market Focus As a direct-to-patient provider of insulin pumps and diabetic testing supplies, Pal Med’s market is diabetes management. Explore opportunities with adjacent diabetes care vendors, clinics, and home healthcare firms that serve similar patient cohorts.

Financial Scope Current revenue is under $1 million, suggesting high growth potential but also a need for scalable support, onboarding, and value demonstration in a competitive medical supplies space.

Tech Footprint Website and tech stack indicate basic online presence (WordPress, PHP) with standard branding assets. There may be opportunities to offer digital marketing, e-commerce optimization, or patient engagement tools to enhance online sales.

Competitive Context Operating in a market with large multi-channel distributors (e.g., Lincare, Apria, AdaptHealth) suggests potential sales plays around integrated supply solutions, bundled devices, and home health partnerships to compete effectively.